Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to WARGO, JENNIFER
Item TypeName
Concept Indoles
Academic Article RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
Academic Article BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice.
Academic Article BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.
Academic Article Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer.
Academic Article COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Academic Article Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Academic Article Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.
Academic Article EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.
Academic Article Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma.
Academic Article An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Academic Article Elucidating distinct roles for NF1 in melanomagenesis.
Academic Article Oncogenic BRAF regulates oxidative metabolism via PGC1a and MITF.
Academic Article TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma.
Academic Article PDGFRa up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.
Academic Article A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
Academic Article Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade.
Academic Article Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics.
Academic Article EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.
Academic Article MITF Modulates Therapeutic Resistance through EGFR Signaling.
Academic Article BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape.
Academic Article Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Academic Article sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Academic Article Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.
Academic Article Interaction of molecular alterations with immune response in melanoma.
Academic Article Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations.
Search Criteria
  • Indoles